- Home
- ULH vs CSTL Comparison
ULH vs CSTL Comparison
Compare ULH & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULH
- CSTL
- Stock Information
- Founded
- ULH 1932
- CSTL 2007
- Country
- ULH United States
- CSTL United States
- Employees
- ULH N/A
- CSTL N/A
- Industry
- ULH Trucking Freight/Courier Services
- CSTL Medical Specialities
- Sector
- ULH Industrials
- CSTL Health Care
- Exchange
- ULH Nasdaq
- CSTL Nasdaq
- Market Cap
- ULH 591.6M
- CSTL 558.7M
- IPO Year
- ULH 2005
- CSTL 2019
- Fundamental
- Price
- ULH $26.25
- CSTL $16.75
- Analyst Decision
- ULH Hold
- CSTL Strong Buy
- Analyst Count
- ULH 1
- CSTL 6
- Target Price
- ULH $29.00
- CSTL $38.33
- AVG Volume (30 Days)
- ULH 69.8K
- CSTL 548.5K
- Earning Date
- ULH 04-24-2025
- CSTL 05-05-2025
- Dividend Yield
- ULH 1.61%
- CSTL N/A
- EPS Growth
- ULH N/A
- CSTL N/A
- EPS
- ULH 3.17
- CSTL N/A
- Revenue
- ULH $1,736,518,000.00
- CSTL $347,083,000.00
- Revenue This Year
- ULH N/A
- CSTL N/A
- Revenue Next Year
- ULH $7.88
- CSTL $1.80
- P/E Ratio
- ULH $8.06
- CSTL N/A
- Revenue Growth
- ULH 1.16
- CSTL 38.43
- 52 Week Low
- ULH $20.60
- CSTL $15.70
- 52 Week High
- ULH $53.29
- CSTL $35.84
- Technical
- Relative Strength Index (RSI)
- ULH 57.46
- CSTL 34.74
- Support Level
- ULH $25.41
- CSTL $15.84
- Resistance Level
- ULH $26.54
- CSTL $17.49
- Average True Range (ATR)
- ULH 1.08
- CSTL 0.90
- MACD
- ULH 0.51
- CSTL -0.18
- Stochastic Oscillator
- ULH 95.12
- CSTL 22.73
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.